Climb Bio, Inc.
CLYM
$7.01
-$0.12-1.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.01% | 26.58% | 27.16% | -540.10% | -110.42% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -89.41% | -88.29% | -89.29% | 3,278.45% | 426.56% |
| Change in Net Operating Assets | -135.39% | -113.55% | -87.51% | 12.31% | -54.89% |
| Cash from Operations | -249.29% | -302.64% | -69,675.44% | -302.94% | 24.45% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.59% | -188.81% | -321.78% | -324.80% | -268.81% |
| Cash from Investing | 102.34% | -146.04% | -336.84% | -330.84% | -275.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.95% | -99.78% | -98.02% | 15,217.43% | 15,474.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 65.60% | -- | -- | -- | -- |
| Cash from Financing | -100.02% | -99.97% | -98.21% | 15,188.19% | 15,444.47% |
| Foreign Exchange rate Adjustments | -100.00% | 75.32% | 115.22% | 2.22% | -86.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -776.15% | -235.52% | -201.32% | -207.67% | -111.88% |